Journal article icon

Journal article

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.

Abstract:
A worker in a polyvinyl chloride factory with rapidly progressive diffuse cutaneous scleroderma was treated with the humanized monoclonal antibody (Mab) CAMPATH-1H. Treatment was followed by rapid and substantial improvement in skin score, which was maintained during followup without additional therapy. The mode of action of CAMPATH-1H and its relationship to clinical improvement are discussed.
Publication status:
Published

Actions


Authors


Isaacs, JD More by this author
Hazleman, BL More by this author
Chakravarty, K More by this author
Expand authors...
Journal:
The Journal of rheumatology
Volume:
23
Issue:
6
Pages:
1103-1106
Publication date:
1996-06-05
ISSN:
0315-162X
URN:
uuid:7f32a4fb-fce5-46f5-8f19-06149a9d0e64
Source identifiers:
27317
Local pid:
pubs:27317

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP